Clinical trial
Intravenous Hydrogen Nanobubbles Effect on Cardiac Physiology and Quality of Life: a Single Blind, Dose-response Study
NCT07085637 is registered in ClinicalTrials.gov with Indonesia Molecule Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intravenous Hydrogen Nanobubbles Effect on Cardiac Physiology and Quality of Life: a Single Blind, Dose-response Study
- Lead sponsor
- Indonesia Molecule Institute
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 19, 2022
- Completion date
- November 4, 2022
- Enrollment
- 52 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
blood pressure, cardiovascular diseases, hypertension